StonvexLoading…
StonvexStonvexStonvexCore line items from ERO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $785.84M | $470.26M | $427.48M | $426.39M |
Operating Income | $270.60M | $108.92M | $95.20M | $129.78M |
Net Income | $266.91M | $-67.79M | $94.30M | $103.07M |
EPS (Diluted) | $2.53 | $-0.66 | $0.98 | $1.10 |
Total Assets | $1.92B | $1.46B | $1.51B | $1.19B |
Total Liabilities | $986.02M | $866.95M | $702.36M | $645.91M |
Cash & Equivalents | $105.44M | $50.40M | $111.74M | $177.70M |
Free Cash Flow OCF − CapEx | $132.38M | $-183.54M | $-284.07M | $-139.39M |
Shares Outstanding | Not available | Not available | Not available | Not available |